UK Awards $17M to Launch Three Stratified Medicine Consortia | GenomeWeb

NEW YORK (GenomeWeb News) – The UK's Medical Research Council has awarded £10.6 million ($17.1 million) to three new multi-partner projects that plan to develop genome-based personalized medicine approaches to treating rheumatoid arthritis, hepatitis, and Gaucher disease.

Funded under MRC's Translational Research Group, these grants will support three research consortia involving more than 50 partners from academia and industry, as well as non-profits and patients from around the UK, MRC said on Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.